Table 1. Plasma levels of lipid, NO products, and cGMP.
Gp1-HCD | Gp2-Arg | Gp3-Cit | Gp4-Arg + Cit | Gp5-Vit | Gp6-Vit + Arg | Gp7-Mix | |
---|---|---|---|---|---|---|---|
T.Chol., mg/dl | 1,758 ± 162 | 1,584 ± 104 | 1,460 ± 210 | 1,350 ± 178 | 1,473 ± 171 | 1,662 ± 162 | 1,257 ± 172 |
Triglycerides, mg/dl | 104.2 ± 7.1 | 120.7 ± 10.5 | 89.8 ± 4.4 | 88.8 ± 4.5 | 98.4 ± 7.1 | 120.5 ± 8.3 | 72.3 ± 6.9 |
HDL-C, mg/dl | 29.1 ± 4.8 | 29.4 ± 3.3 | 26.0 ± 3.2 | 34.4 ± 4.1 | 33.5 ± 5.3 | 33.9 ± 4.5 | 35.8 ± 4.1 |
NO2− + NO3−, nM | 25.1 ± 2.6 | 27.3 ± 4.1 | 25.2 ± 4.0 | 35.1 ± 5.2* | 17.2 ± 3.6 | 26.8 ± 1.8 | 29.1 ± 2.1* |
cGMP, pg/ml | 19.1 ± 3.3 | 18.9 ± 2.8 | 32.3 ± 3.7 | 36.7 ± 5.2* | 19.3 ± 4.5 | 32.9 ± 6.3 | 41.0 ± 6.1* |
Body weight, kg | 3.12 ± 0.31 | 2.96 ± 0.40 | 3.11 ± 0.31 | 3.02 ± 0.21 | 3.23 ± 0.34 | 2.97 ± 0.23 | 3.02 ± 0.32 |
Refer to Materials and Methods for the definitions of the treatment groups. Data are expressed as the mean ± SEM from six rabbits per group. T. Chol, total cholesterol; HDL-C, high-density lipoprotein-cholesterol.
Significant difference (P < 0.05) vs. GpI-HCD.